The PPMD team is joined by leading Duchenne researchers to discuss exciting areas of research in development that hold promise for Duchenne, such as gene editing and non-viral delivery. Panelists: Kevin Flanigan, MD, Nationwide Children’s Hospital Melissa Spencer, PhD, UCLA 6 years ago 2020 PPMD Virtual Conference: Live Sessions,Conferences & Meetings You may also like 22:59 Italfarmaco 6 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 21:06 Capricor Therapeutics 6 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 18:40 Sarepta Therapeutics 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 17:20 Pfizer Inc. 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 21:45 Audentes Therapeutics 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 19:10 Solid Biosciences 6 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 13:05 Astellas Pharma 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 12:31 Santhera Pharmaceuticals 6 years ago Conferences & Meetings,In the Pipeline: Downstream Targets «1…2223242526…29»Page 24 of 29